What is the role of blood products in austere field care, and when should they be used?

• A. For all trauma patients regardless of status
• B. Only after reaching a hospital
• C. For hemorrhagic shock when available
• D. Never in austere field care

Answer: (C)

The key idea is that blood products in austere field care are used to treat hemorrhagic shock by restoring both oxygen delivery and coagulation factors, and they should be used when there is ongoing life-threatening bleeding and transfusion capability is available.

When bleeding is severe enough to cause shock, crystalloids alone often aren’t enough and can worsen coagulopathy by diluting clotting factors. Blood products—red blood cells to carry oxygen, plasma to supply clotting factors, and platelets to help clot formation—address both the oxygen debt and the hemostatic deficit. In austere settings, the goal is early, balanced resuscitation with available blood products to improve survival, rather than delaying until hospital transfer.

So, using blood products is appropriate for hemorrhagic shock when they’re accessible. They aren’t required for all trauma patients regardless of status, they aren’t something reserved only for hospital care, and they’re not never used in austere care. The emphasis is on timely administration for those with significant bleeding, whenever feasible.